Showing results (331-340 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|July 14, 2015
Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trialLucilla Poston, Ruth Bell, Helen Croker, et al.
The Lancet. Diabetes & Endocrinology|July 14, 2015
Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trialCarolyn Chiswick, Rebecca M Reynolds, Fiona Denison, et al.
The Lancet. Diabetes & Endocrinology|July 14, 2015
Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1Christopher J Yates, Paul J Newey, Rajesh V Thakker
The Lancet. Diabetes & Endocrinology|July 26, 2016
Association between borderline neonatal thyroid-stimulating hormone concentrations and educational and developmental outcomes: a population-based record-linkage studySamantha J Lain, Jason P Bentley, Veronica Wiley, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2020
Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trialJulius Simoni Leere, Jesper Karmisholt, Maciej Robaczyk, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2020
Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetesDominic Ehrmann, Bernhard Kulzer, Timm Roos, et al.
The Lancet. Diabetes & Endocrinology|March 5, 2019
Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort studyOnyebuchi E Okosieme, Peter N Taylor, Carol Evans, et al.
The Lancet. Diabetes & Endocrinology|February 27, 2017
Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects studyLena M S Carlsson, Kajsa Sjöholm, Cecilia Karlsson, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2017
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trialJohn R Petrie, Nishi Chaturvedi, Ian Ford, et al.
The Lancet. Diabetes & Endocrinology|September 28, 2016
Association between exogenous testosterone and cardiovascular events: an overview of systematic reviewsOluwadamilola Onasanya, Geetha Iyer, Eleanor Lucas, et al.
Pageof 93